Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.22
-0.11 (-1.97%)
Sep 2, 2025, 11:04 AM - Market open

Serina Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
5347---
Enterprise Value
4955---
Last Close Price
5.325.01---
PS Ratio
419.49840.25---
PB Ratio
33.1392.63---
P/TBV Ratio
-73.41---
EV/Sales Ratio
375.80990.71---
Debt / Equity Ratio
0.220.910.90-0.771.19
Asset Turnover
0.010.010.640.44-
Quick Ratio
1.701.555.391.223.53
Current Ratio
2.242.405.391.253.58
Return on Equity (ROE)
--485.36%594.25%--
Return on Assets (ROA)
-132.37%-124.04%-19.46%-105.01%-
Return on Capital (ROIC)
--221.85%-26.28%-1390.61%-
Earnings Yield
-23.30%-23.68%---
FCF Yield
-28.75%-36.47%---
Buyback Yield / Dilution
-138.29%-0.11%-242.70%-0.01%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q